Myomo
19 hedge funds and large institutions have $5.96M invested in Myomo in 2020 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 1 closing their positions.
500% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 1
491% more capital invested
Capital invested by funds: $1.01M → $5.96M (+$4.95M)
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
27% more funds holding
Funds holding: 15 → 19 (+4)
13.12% more ownership
Funds ownership: 6.14% → 19.27% (+13%)
Top Buyers
| 1 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$624K |
| 2 |
Renaissance Technologies
New York
|
+$217K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$186K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$145K |
| 5 |
Two Sigma Investments
New York
|
+$99.2K |
Top Sellers
| 1 |
UBS Group
Zurich,
Switzerland
|
-$2.68K |
MYO Hedge Fund Activity: Q4 2020 in Review
19 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Myomo (MYO) for Q4 2020, worth a combined $5.96M — up 491% from $1.01M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new MYO positions and 1 closed out — a net gain of 5 holders — while 4 added to existing stakes and 1 trimmed.
The largest buyer was Worth Venture Partners, opening a new position worth an estimated $624K. The largest seller was UBS Group, cutting an estimated $2.68K.
- 19 institutional investors held Myomo (MYO) as of Q4 2020, up from 15 in Q3 2020.
- Funds reported $5.96M of Myomo stock for Q4 2020, up 491% quarter-over-quarter.
- 6 funds opened new Myomo positions in Q4 2020 and 1 closed out, a net change of +5 holders.
- The largest Myomo buyer in Q4 2020 was Worth Venture Partners, an estimated $624K added.
- The largest Myomo seller in Q4 2020 was UBS Group, an estimated $2.68K sold.
Based on aggregated 13F filings for Q4 2020.